Waypoint Bio

Waypoint Bio is a VC-backed biotech startup [2] founded in 2021 that focuses on developing cell therapies for solid tumors [2]. The company is recognized as part of the New York AI scene [1]. According to available professional profiles, Waypoint Bio operates in the biotechnology research industry [3] and maintains a team of approximately 20 employees [3].

Something wrong or missing? Send a correction. Fixed within 24 hours.